Capricor Therapeutics (CAPR) Operating Margin (QoQ) (2011 - 2024)
Powered by 
Analysis
Capricor Therapeutics (CAPR) Operating Margin (QoQ) (2011 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Capricor Therapeutics | 543.30 Mn | 543.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 50,628.00 |
| Sep 30, 2024 | -28,338.00 |
| Jun 30, 2024 | -18,921.00 |
| Mar 31, 2024 | -9,206.00 |
| Dec 31, 2023 | 10,037.00 |
| Sep 30, 2023 | 8,679.00 |
| Jun 30, 2023 | 7,628.00 |
| Mar 31, 2023 | 56,629.00 |
| Dec 31, 2022 | -43,332.00 |
| Jun 30, 2021 | 1.02 Mn |
| Mar 31, 2021 | -541,575.00 |
| Dec 31, 2020 | 1.60 Mn |
| Sep 30, 2020 | -1.62 Mn |
| Jun 30, 2020 | -585,978.00 |
| Mar 31, 2020 | -46,706.00 |
| Dec 31, 2019 | 47,778.00 |
| Sep 30, 2019 | -64,227.00 |
| Jun 30, 2019 | 60,599.00 |
| Mar 31, 2019 | -59,927.00 |
| Dec 31, 2018 | 139,271.00 |